View More Recent Stories

Apr 1, 2025 07:01AM Compass Therapeutics, Inc (CMPX) Reports CTX-009 Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study
Mar 31, 2025 04:07PM Compass Therapeutics (CMPX) to Host Webcast Highlighting Top-Line Clinical Data from the Ongoing Randomized Phase 2/3 Study Evaluating Tovecimig in Patients with Biliary Tract Cancer
Mar 10, 2025 04:31PM Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)
Feb 28, 2025 04:39AM Compass Therapeutics, Inc. (CMPX) Misses Q4 EPS by 1c
Feb 19, 2025 04:05AM Piper Sandler Starts Compass Therapeutics (CMPX) at Overweight
Jan 8, 2025 08:04AM Compass Therapeutics (CMPX) Provides Corporate Update and Announces Advancement of a New Drug Candidate
Dec 10, 2024 08:12AM Compass Therapeutics (CMPX) Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer
Nov 12, 2024 08:01AM Compass Therapeutics, Inc. (CMPX) Tops Q3 EPS by 3c
Sep 16, 2024 06:49AM Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) to Buy
Aug 12, 2024 08:01AM Compass Therapeutics, Inc. (CMPX) Reports In-Line Q2 EPS
View More Recent Stories